Estrogen and estrogen receptors in cardiovascular oxidative stress

Pflugers Archiv European Journal of Physiology

Volumn 465, Issue 5, 2013, Pages 739-746

  Arias Loza, Paula Anahi ^a   Muehlfelder, Melanie ^a   Pelzer, Theo ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

17 Estradiol; Cardiovascular system; Estrogens; Oxidative stress; ROS

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; SEX HORMONE; SUPEROXIDE DISMUTASE;

APOPTOSIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL FUNCTION; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART WORK; HORMONE ACTION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR SYSTEM; ESTROGENS; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; RECEPTORS, ESTROGEN;

EID: 84878018470     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-013-1247-7     Document Type: Review

References (68)

1. Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357(Pt 3):593-615
2. Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, Schmidt HH (2012) The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69(14):2327-2343. doi: 10.1007/s00018-012-1010-9
3. Arias-Loza PA, Hu K, Frantz S, Dienesch C, Bayer B, Wu R, Ertl G, Pelzer T (2011) Medroxyprogesterone acetate aggravates oxidative stress and left ventricular dysfunction in rats with chronic myocardial infarction. Toxicol Pathol 39(5):867-878. doi: 10.1177/0192623311410441
4. Barbacanne MA, Rami J, Michel JB, Souchard JP, Philippe M, Besombes JP, Bayard F, Arnal JF (1999) Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res 41(3):672-681
5. Baumer AT, Wassmann S, Ahlbory K, Strehlow K, Muller C, Sauer H, Bohm M, Nickenig G (2001) Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifene. Br J Pharmacol 134(3):579-584. doi: 10.1038/sj.bjp.0704299
6. Booth EA, Lucchesi BR (2007) Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 293(3):H1408-H1415. doi: 10.1152/ajpheart.00993.2006
7. Borras C, Gambini J, Lopez-Grueso R, Pallardo FV, Vina J (2010) Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim Biophys Acta 1802(1):205-211. doi: 10.1016/j.bbadis.2009.09.007
8. Brilla CG, Weber KT (1992) Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 120(6):893-901
9. Busserolles J, Mazur A, Gueux E, Rock E, Rayssiguier Y (2002) Metabolic syndrome in the rat: females are protected against the pro-oxidant effect of a high sucrose diet. Exp Biol Med (Maywood) 227(9):837-842
10. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP (2003) Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284(5):H1560-H1569. doi: 10.1152/ajpheart.01087.2002
11. Crabbe DL, Dipla K, Ambati S, Zafeiridis A, Gaughan JP, Houser SR, Margulies KB (2003) Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 41(2):300-306
12. Dean SA, Tan J, White R, O'Brien ER, Leenen FH (2006) Regulation of components of the brain and cardiac renin-angiotensin systems by 17beta-estradiol after myocardial infarction in female rats. Am J Physiol Regul Integr Comp Physiol 291(1):R155-R162. doi: 10.1152/ajpregu.00497.2005
13. Deschamps AM, Murphy E, Sun J (2010) Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc Med 20(3):73-78. doi: 10.1016/j.tcm.2010.05.001
14. Ejima K, Nanri H, Araki M, Uchida K, Kashimura M, Ikeda M (1999) 17Beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. Eur J Endocrinol 140(6):608-613
15. Florian M, Freiman A, Magder S (2004) Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 69(13-14):779-787. doi: 10.1016/j.steroids.2004.09.008
16. Foryst-Ludwig A, Kintscher U (2010) Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 122(1-3):74-81. doi: 10.1016/j.jsbmb.2010.06.012
17. Furchgott RF (1999) Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep 19(4):235-251
18. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST (2003) Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 23(1):38-44
19. Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108(16):1912-1916. doi: 10.1161/01.CIR.0000093660.86242.BB
20. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74(6):1141-1148
21. Hayward CS, Kelly RP, Collins P (2000) The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46(1):28-49
22. Hernandez I, Delgado JL, Diaz J, Quesada T, Teruel MJ, Llanos MC, Carbonell LF (2000) 17Beta-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 279(5):R1599-R1605
23. Javeshghani D, Schiffrin EL, Sairam MR, Touyz RM (2009) Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia. J Am Soc Hypertens 3(5):295-305. doi: 10.1016/j.jash.2009.07.002
24. Jazbutyte V, Kehl F, Neyses L, Pelzer T (2009) Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria. Biochem Biophys Res Commun 384(4):450-454. doi: 10.1016/j.bbrc.2009.04.139
25. Jeanes HL, Tabor C, Black D, Ederveen A, Gray GA (2008) Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist. J Endocrinol 197(3):493-501. doi: 10.1677/JOE-08-0071
26. Jeong EM, Liu M, Sturdy M, Gao G, Varghese ST, Sovari AA, Dudley SC Jr (2012) Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol 52(2):454-463. doi: 10.1016/j.yjmcc.2011.09.018
27. Kannel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85(4):447-452
28. Kauser K, Rubanyi GM (1994) Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 267(6 Pt 2):H2311-H2317
29. Kim JK, Pedram A, Razandi M, Levin ER (2006) Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem 281(10):6760-6767. doi: 10.1074/jbc.M511024200
30. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E (2010) Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 106(11):1681-1691. doi: 10.1161/CIRCRESAHA.109.213645
31. Lam KK, Lee YM, Hsiao G, Chen SY, Yen MH (2006) Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 13(2):294-302. doi: 10.1097/01.gme.0000182806. 99137.5e
32. Lassegue B, San Martin A, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110(10):1364-1390. doi: 10.1161/CIRCRESAHA.111.243972
33. Laufs U, Adam O, Strehlow K, Wassmann S, Konkol C, Laufs K, Schmidt W, Bohm M, Nickenig G (2003) Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 278(8):5956-5962. doi: 10.1074/jbc.M209813200
34. Li L, Hisamoto K, Kim KH, Haynes MP, Bauer PM, Sanjay A, Collinge M, Baron R, Sessa WC, Bender JR (2007) Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc Natl Acad Sci U S A 104(42):16468-16473. doi: 10.1073/pnas.0704315104
35. Li JM, Shah AM (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287(5):R1014-R1030. doi: 10.1152/ajpregu.00124.2004
36. McNeill AM, Kim N, Duckles SP, Krause DN, Kontos HA (1999) Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30(10):2186-2190
37. Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340(23):1801-1811. doi: 10.1056/ NEJM199906103402306
38. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308(5728):1583-1587. doi: 10.1126/science.1112062
39. Moreau KL, Meditz A, Deane KD, Kohrt WM (2012) Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Am J Physiol Heart Circ Physiol 302(5):H1211-H1218. doi: 10.1152/ajpheart.01065.2011
40. Muehlfelder M, Arias-Loza PA, Fritzemeier KH, Pelzer T (2012) Both estrogen receptor subtypes, ERalpha and ERbeta, prevent aldosterone-induced oxidative stress in VSMC via increased NADPH bioavailability. Biochem Biophys Res Commun 423(4):850-856. doi: 10.1016/j.bbrc.2012.06.053
41. Murase T, Hattori T, Ohtake M, Nakashima C, Takatsu M, Murohara T, Nagata K (2012) Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr(fa)/Lepr(fa) rats as a new animal model of metabolic syndrome. Hypertension 59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976
42. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Bohm M (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97(22):2197-2201
43. Ortmann J, Veit M, Zingg S, Di Santo S, Traupe T, Yang Z, Volzmann J, Dubey RK, Christen S, Baumgartner I (2011) Estrogen receptor-alpha but not -beta or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. J Clin Endocrinol Metab 96(1):220-228. doi: 10.1210/jc.2010-0943
44. Paravicini TM, Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2):S170-S180. doi: 10.2337/dc08-s247
45. Perjes A, Kubin AM, Konyi A, Szabados S, Cziraki A, Skoumal R, Ruskoaho H, Szokodi I (2012) Physiological regulation of cardiac contractility by endogenous reactive oxygen species. Acta Physiol (Oxf) 205(1):26-40. doi: 10.1111/j.1748-1716.2012.02391.x
46. Poornima IG, Parikh P, Shannon RP (2006) Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98(5):596-605. doi: 10.1161/01.RES.0000207406.94146.c2
47. Raedschelders K, Ansley DM, Chen DD (2012) The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133(2):230-255. doi: 10.1016/j.pharmthera.2011.11. 004
48. Razmara A, Sunday L, Stirone C, Wang XB, Krause DN, Duckles SP, Procaccio V (2008) Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells. J Pharmacol Exp Ther 325(3):782-790. doi: 10.1124/jpet.107.134072
49. Schramm A, Matusik P, Osmenda G, Guzik TJ (2012) Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 56(5-6):216-231. doi: 10.1016/j.vph.2012.02.012
50. Smith PJ, Ornatsky O, Stewart DJ, Picard P, Dawood F, Wen WH, Liu PP, Webb DJ, Monge JC (2000) Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation 102(24):2983-2989
51. Sovershaev MA, Egorina EM, Andreasen TV, Jonassen AK, Ytrehus K (2006) Preconditioning by 17beta-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. Am J Physiol Heart Circ Physiol 291(4):H1554-H1562. doi: 10.1152/ajpheart.01171.2005
52. Stirone C, Boroujerdi A, Duckles SP, Krause DN (2005) Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 67(1):105-113. doi: 10.1124/mol.104.004465
53. Stirone C, Chu Y, Sunday L, Duckles SP, Krause DN (2003) 17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol 478(1):35-38
54. Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, Bohm M, Nickenig G (2003) Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93(2):170-177. doi: 10.1161/01.RES.0000082334.17947.11
55. Szabo C (2003) Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141:105-112
56. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45(2):205-251
57. Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, Marz W (2010) Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J 31(10):1237-1247. doi: 10.1093/eurheartj/ehq019
58. Tschudi MR, Mesaros S, Luscher TF, Malinski T (1996) Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 27(1):32-35
59. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S, Kondo T (2006) 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 281(19):13092-13102. doi: 10.1074/jbc.M601984200
60. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95(16):9220-9225
61. Wagner AH, Schroeter MR, Hecker M (2001) 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15(12):2121-2130. doi: 10.1096/fj.01-0123com
62. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rosen R, Bohm M, Nickenig G (2002) Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105(17):2083-2091
63. Wing LY, Chen YC, Shih YY, Cheng JC, Lin YJ, Jiang MJ (2009) Effects of oral estrogen on aortic ROS-generating and-scavenging enzymes and atherosclerosis in apoE-deficient mice. Exp Biol Med (Maywood) 234(9):1037-1046. doi: 10.3181/0811-RM-332
64. Wong CM, Yung LM, Leung FP, Tsang SY, Au CL, Chen ZY, Yao X, Cheng CH, Lau CW, Gollasch M, Huang Y (2008) Raloxifene protects endothelial cell function against oxidative stress. Br J Pharmacol 155(3):326-334. doi: 10.1038/bjp.2008.262
65. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW (2004) Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A 101(12):4130-4135. doi: 10.1073/pnas.0306948101
66. Yung LM, Wong WT, Tian XY, Leung FP, Yung LH, Chen ZY, Yao X, Lau CW, Huang Y (2011) Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats. PLoS One 6(3):e17437. doi: 10.1371/journal.pone.0017437
67. Zhang L, Fujii S, Kosaka H (2007) Effect of oestrogen on reactive oxygen species production in the aortas of ovariectomized Dahl salt-sensitive rats. J Hypertens 25(2):407-414. doi: 10.1097/HJH.0b013e328010beee
68. Zhang Y, Tocchetti CG, Krieg T, Moens AL (2012) Oxidative and nitrosative stress in the maintenance of myocardial function. Free Radic Biol Med 53(8):1531-1540. doi: 10.1016/j.freeradbiomed.2012.07.010